Collectionner le produit
Détails du produit
Product Specifications
Assay TypeSandwich-ELISAAnalyteG-CSFFormat96T (8×12 strips)Reactivity/Regulatory StatusRUOSensitivity＜9.375 pg/mLStandard Curve Range9.375 pg/mL-300 pg/mLAssay Time2 hr 50 minSuitable Sample TypeFor the detection and quantitative determination of G-CSF in human serum, plasma and cell culture supernates.Sample volume100 μLProduct Overview
resDetect™ Human G-CSF ELISA Kit uses the ELISA sandwich technique. It accurately detects and measures human G-CSF in cell culture supernatants, serum, and plasma. Chemotherapy often causes bone marrow suppression, with neutropenia being common. The extent and duration of neutropenia are linked to patient infection and death risks, and may affect chemotherapy. As the key drug for granulocytopenia, G-CSF can be precisely detected by this kit, which supports medical research.
Storage
1. Unopened kit should be stored at 2℃-8℃ upon receiving.
2. Find the expiration date on the outside packaging and do not use reagents past their expiration date.
3. The opened kit should be stored per components table. The shelf life is 30 days from the date of opening.
Materials Provided
IDComponentsSizeRES107-C01Pre-coated Anti-G-CSF Antibody Microplate1 plate (8×12 strips)RES107-C02Human G-CSF Standard15 μgRES107-C03Biotin-Anti-G-CSF Antibody20 μgRES107-C04Streptavidin-HRP50 μLRES107-C0510×Washing Buffer50 mLRES107-C062×Dilution Buffer50 mLRES107-C07Substrate Solution12 mLRES107-C08Stop Solution7 mLACRO Quality Management System
Les clients ont également consulté
Affichage des données
Typical Data
Please refer to DS document for the assay protocol.
For each experiment, a standard curve needs to be set for each micro-plate, and the specific OD value may vary depending on different laboratories, testers, or equipments. The following example data is for reference only.
Avis des utilisateurs Publier un commentaire
Progrès de frontière
Progrès du développement médicamenteux- Nom anglais：
Granulocyte colony-stimulating factor
- Catégorie：
- Nombre de médicaments répertoriés：
0 Détails
- Nombre de médicaments cliniques：
3 Détails
- Étape de développement la plus élevée：
Phase 2 Clinical
Contact Us
Drug Candidate Licensing
